$FLGT insider trading
Over the last 12 months, Fulgent Genetics insiders reported no purchases and 15 sales totaling $678K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $678K 15 events
- Events · 12m
- 15 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 1,673 | $19.66 | $33K | -0.2% | — |
| Sep 2, 2026 | Xie JianPresident and COO · O | ▼ Sale | 2,127 | $19.66 | $42K | -0.6% | — |
| Aug 27, 2026 | Xie JianPresident and COO · O | ▼ Sale | 1,193 | $19.91 | $24K | -0.3% | — |
| Aug 27, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 939 | $19.91 | $19K | -0.1% | — |
| Jun 2, 2026 | Xie JianPresident and COO · O | ▼ Sale | 2,146 | $17.89 | $38K | -0.6% | — |
| Jun 2, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 1,688 | $17.89 | $30K | -0.2% | — |
| May 27, 2026 | Xie JianPresident and COO · O | ▼ Sale | 1,201 | $17.6 | $21K | -0.3% | — |
| May 27, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 945 | $17.6 | $17K | -0.1% | — |
| Dec 2, 2025 | Xie JianPresident and COO · O | ▼ Sale | 1,140 | $28.33 | $32K | -0.3% | — |
| Dec 2, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 1,075 | $28.33 | $30K | -0.1% | — |
| Nov 28, 2025 | Xie JianPresident and COO · O | ▼ Sale | 1,198 | $29.57 | $35K | -0.4% | — |
| Nov 28, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 943 | $29.57 | $28K | -0.1% | — |
| Nov 24, 2025 | Xie JianPresident and COO · O | ▼ Sale | 681 | $30.47 | $21K | -0.2% | — |
| Nov 24, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 535 | $30.47 | $16K | -0.1% | — |
| Nov 19, 2025 | Xie JianPresident and COO · O | ▼ Sale | 10,000 | $29.1 | $291K | -2.8% | — |
| Sep 3, 2025 | Xie JianPresident and COO · O | ▼ Sale | 1,128 | $22.03 | $25K | -0.3% | — |
| Sep 3, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 1,063 | $22.03 | $23K | -0.1% | — |
| Aug 27, 2025 | Xie JianPresident and COO · O | ▼ Sale | 1,199 | $21.48 | $26K | -0.3% | — |
| Aug 27, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 943 | $21.48 | $20K | -0.1% | — |
| Aug 25, 2025 | Xie JianPresident and COO · O | ▼ Sale | 696 | $21.5 | $15K | -0.2% | — |
| Aug 25, 2025 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 548 | $21.5 | $12K | -0.1% | — |
Every $FLGT filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Fulgent Genetics filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $FLGT feed.